|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 4 July 2006
doi: 10.1242/jcs.03043
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Department of Pathology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2 Laboratory of Molecular Biochemistry, School of Life Science, Tokyo University of Pharmacy and Life Science, Tokyo 192-0392, Japan
3 Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan
4 Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
5 Division of Surgical Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
6 Department of Medical Technology, Nagoya University of Health Sciences, Higashi-ku, Nagoya 461-8673, Japan
7 Division of Molecular Pathology, Center for Neurological Disease and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
* Author for correspondence (e-mail: mtakaha{at}med.nagoya-u.ac.jp)
Accepted 9 May 2006
| Summary |
|---|
|
|
|---|
Key words: Dok-4, GDNF, RET tyrosine kinase, Rap1, MAPK, Neuronal differentiation
| Introduction |
|---|
|
|
|---|
The tyrosine kinase receptor RET plays an important role in the development of the enteric nervous system and the kidney (Manié et al., 2001
; Takahashi, 2001
; Airaksinen and Saarma, 2002
). It has been demonstrated that members of the glial cell line-derived neurotrophic factor (GDNF) family, which includes GDNF, neuturin, artemin, and persephin, act as RET ligands and function as survival and/or differentiation factors in various central and peripheral neurons. Thus, RET activation is mediated by the binding of these neurotrophic factors to glycosylphosphatidylinositol-anchored co-receptors termed GDNF family receptors
1-4 (GFR
1-4) (Jing et al., 1996
; Treanor et al., 1996
; Klein et al., 1997
; Airaksinen and Saarma, 2002
), which result in the activation of several signaling pathways, including the Ras/ERK, phosphatidylinositol-3 kinase [PI(3)K]/AKT, p38MAPK, phospholipase C
, and Rac/c-Jun N-terminal kinase (JNK) pathways (Besset et al., 2000
; Hayashi et al., 2000
; Hayashi et al., 2001
; Segouffin-Carius and Billaud, 2000
; Fukuda et al., 2002
; Fukuda et al., 2005
). Ablation of the Gdnf or Ret genes in mice results in the absence or severe hypoplasia of the kidneys, enteric nervous system defects, and reduced numbers of some peripheral and central neurons (Schuchardt et al., 1994
; Moore et al., 1996
; Pichel et al., 1996
; Sanchez et al., 1996
). Loss-of-function mutations of the RET gene in humans lead to the development of Hirshsprung's disease (Edery et al., 1994
; Romeo et al., 1994
), a congenital malformation characterized by the absence or decreased number of intrinsic ganglion cells in the gastrointestinal tract. Given the diverse roles of RET in the regulation of neuronal differentiation/maturation in the central and enteric nervous systems, it is important to understand the complex intracellular signaling pathways stimulated by RET activation. However, despite considerable progress in understanding the signaling pathways that regulate RET-dependent cell survival and proliferation, the molecular basis underlying RET-dependent neuronal differentiation is still poorly understood.
Recently, putative signaling proteins Dok-4, -5, and -6 were described as new members of the p62dok (downstream of kinase) family that appeared to mediate RET-mediated neurite outgrowth (Grimm et al., 2001
; Crowder et al., 2004
). p62dok family proteins were originally identified as substrates of several tyrosine kinases and mediators of several cytokine signaling pathways, and have emerged as a subgroup of an expanding range of signaling molecules composed of N-terminal tandem pleckstrin homology (PH) and phosphotyrosine-binding (PTB) domains (Carpino et al., 1997
; Yamanashi and Baltimore, 1997
; Cristofano et al., 1998
; Cong et al., 1999
; Grimm et al., 2001
). Dok-4, -5 and -6 constitute a subclass of the p62dok family and are highly expressed in the developing nervous system, as opposed to Dok-1, -2 and -3, which are mainly expressed in hematopoietic tissues (Nelms et al., 1998
; Cong et al., 1999
; Lemay et al., 2000
; Grimm et al., 2001
; Cai et al., 2003
; Crowder et al., 2004
). It has been shown by in situ hybridization of mouse embryos that Dok-4, -5 and -6 colocalize with RET to the ventral part of the neural tube, dorsal root ganglia, cranial sensory ganglia, and/or the ureteric buds of the developing kidney, which suggests that they function downstream of RET in vivo. Previous studies have shown that Dok-4, -5 and -6 directly associate with the tyrosine at position 1062 of RET following phosphorylation in response to GDNF stimulation (Grimm et al., 2001
; Crowder et al., 2004
), and that overexpression of Dok-4 and -5 promotes neurite outgrowth in rat PC12 cells (Grimm et al., 2001
). However, this latter study involved the exogenous expression of an EGFR (epidermal growth factor receptor)/RET chimeric receptor fused at the C-terminus with Dok proteins in PC12 cells.
In the present study, we attempted to characterize the role of endogenous Dok-4 in RET-dependent neurite outgrowth. We used a TGW human neuroblastoma cell line that had the advantage of expressing RET, GFR
-1, and Dok-4 endogenously. Through the use of small interfering RNA (siRNA) specific to Dok-4, we found that Dok-4 was crucial for RET-dependent neurite outgrowth through the induction of sustained ERK1/2 activation. Moreover, we also found a possible function for Dok-4 in activating Rap1, which occurs downstream of RET and regulates neurite outgrowth in TGW cells.
| Results |
|---|
|
|
|---|
-1 (Nozaki et al., 1998
|
To examine the subcellular localization of Dok-4, we immunofluorescently stained TGW cells with anti-Dok-4 Ab. Results indicated that Dok-4 was mainly localized to the plasma membrane in TGW cells (Fig. 1Ba, left panel). When TGW cells were transfected with Dok-4 siRNA, expression of Dok-4 was almost undetectable, which again indicated the specificity of the immunostaining (Fig. 1Ba, right panel). TGW cells stimulated with GDNF undergo morphological changes and start to extend neurites (Nozaki et al., 1998
). Dok-4 was localized to the extended neurites and their tips as well as to the plasma membrane in GDNF-treated cells (Fig. 1Bb), which suggested that Dok-4 constitutively associated with the plasma membrane independent of GDNF stimulation.
We next examined the effect of siRNA-mediated knockdown of Dok-4 expression on neurite outgrowth from TGW cells following GDNF stimulation for 48 hours. Compared with control siRNA-transfected cells, Dok-4 siRNA-transfected cells showed short neurites in response to GDNF (Fig. 1Cc,d). To test whether the addition of exogenous Dok-4 could restore the defective neurite outgrowth observed in knockdown cells, we constructed a V5-fused siRNA-resistant (siRNAr) version of Dok-4 that harbored silent mutations (Fig. 1Ca,b). TGW cells were transiently transfected with siRNAr-Dok-4-V5, incubated with GDNF for 48 hours, and then immunostained with anti-V5 antibody. As shown in Fig. 1Cc,d, siRNAr-Dok-4-V5 expression fully restored neurite outgrowth in response to GDNF. These results suggested that Dok-4 was a crucial mediator of GDNF/RET signaling-induced neurite outgrowth in TGW cells.
Neurite outgrowth induced by Dok-4 is mediated by the ERK pathway
To examine the effect of Dok-4 overexpression on neurite outgrowth, we established TGW cell lines that stably expressed human wild-type Dok-4 [TGW(Dok-4)] (Fig. 2Aa). Overexpression of Dok-4 markedly enhanced neurite outgrowth by TGW cells after GDNF stimulation (Fig. 2Ab,B). The degree of neurite outgrowth was quantified, and results confirmed using three clones. The Ras/ERK, PI(3)K/AKT, and Rac/JNK-dependent pathways have been implicated in GDNF-mediated cell proliferation, neurite outgrowth, cell migration and/or cytoskeleton remodeling (Ichihara et al., 2004
; Kodama et al., 2005
). Using selective kinase inhibitors, we examined whether the blockade of each of these pathways could inhibit GDNF-induced neurite outgrowth (Fig. 2Ab,B). Blockade of the ERK pathway by the MEK1 inhibitor PD98059 was the most effective in preventing neurite outgrowth by TGW(Dok-4) cells following GDNF treatment, whereas the PI(3)K inhibitor LY294002 and the JNK inhibitor SP600125 exhibited only mild to moderate effects. Thus, it appeared that Dok-4-induced neurite outgrowth was highly dependent on the ERK pathway rather than on the PI(3)K or JNK pathways.
|
|
Dok-4 induces a sustained activation of ERK in TGW cells
It has already been shown that sustained ERK activation mediated by neurotrophic factors is a hallmark of the differentiating response in neurons, as opposed to the transient activation kinetics observed during cell proliferation (Marshall, 1995
; York et al., 1998
). Because our data indicated a link between Dok-4 and ERK activation, we attempted to determine whether Dok-4 potentiated sustained ERK activation in response to GDNF in TGW cells. TGW cells that overexpressed Dok-4 [TGW(Dok-4)] were stimulated with GDNF for varying lengths of time under serum starvation conditions, and were then analyzed for ERK activation by western blotting. A high level of ERK phosphorylation was maintained until 24 hours after GDNF stimulation in TGW(Dok-4) cells (Fig. 3 and supplementary material Fig. S2). By contrast, ERK phosphorylation significantly decreased 24 hours after stimulation both in parental TGW cells and in Dok-4 knockdown cells [TGW(Dok-4 siRNA)]. In addition, three independent experiments showed that the level of phosphorylated ERK at 6 hours after GDNF stimulation was considerably lower in TGW(Dok-4 siRNA) cells than in parental TGW cells (Fig. 3). Enhanced activation of AKT but not JNK was also observed in TGW(Dok-4) cells, which suggested that Dok-4 might also have some role in the PI(3)K/AKT signaling pathway.
Conserved tyrosine residues in Dok-4 are crucial for sustained ERK activation and neurite outgrowth
Dok-4 has been reported to undergo tyrosine phosphorylation in cells that overexpress RET (Grimm et al., 2001
). However, the role of tyrosine phosphorylation in GDNF/RET signaling has not yet been established. Therefore, we investigated whether Dok-4 contained tyrosine residues important for biochemical and biological responses. While human Dok-4 contains a total of 14 tyrosine residues, only three tyrosines (at amino acid positions 187, 220 and 270) are conserved across species, including human, rat, mouse and Xenopus laevis, as well as with Dok-5 and -6 (Fig. 4A). We replaced each of these three tyrosines with phenylalanine (Y187F, Y220F and Y270F, respectively). As a control, the tyrosine at position 255 in Dok-4, which is not conserved with Dok-5 and -6, was also replaced with phenylalanine (Y255F). Each mutant was stably expressed in TGW cells as a V5 epitope-tagged protein. Dok-4 was immunoprecipitated with anti-V5 antibody after GDNF stimulation, and analyzed by western blot using anti-V5 or anti-phosphotyrosine (4G10) antibody. As shown in Fig. 4Ba, tyrosine phosphorylation of each mutant was detected, suggesting that Dok-4 appears to contain multiple phosphorylation sites. On the other hand, its tyrosine phosphorylation was undetectable in the GDNF-untreated cells (data not shown).
|
We also examined the phenotypic changes of TGW cells expressing mutant Dok-4 proteins after GDNF treatment. TGW cells that stably expressed mutant Dok-4 were serum-starved for 6 hours, incubated with GDNF for 48 hours, and then examined for the degree of neurite extension (Fig. 5A,B). Consistent with the findings for ERK activation, TGW cells that expressed Y187F, Y220F or Y270F showed no significant neurite outgrowth in response to GDNF compared with parental TGW cells. By contrast, the Y255F mutant led to enhanced neurite outgrowth, although the degree of outgrowth was still lower than that induced by wild-type Dok-4.
|
|
To test whether Rap1 activation induced neurite outgrowth, TGW cells were transfected with a dominant active Rap1 mutant (RapV12) (Kitayama et al., 1990
), in which the glycine at position 12 (within the GTPase domain) was replaced with valine, and neurite length measured after 48 hours (Fig. 6B). Our results indicated that expression of green fluorescent protein (GFP)-tagged RapV12 induced significant neurite outgrowth by TGW cells in the absence of GDNF stimulation compared with control cells that expressed only GFP. Moreover, exogenous expression of RapV12 also enhanced neurite outgrowth in Dok-4 knockdown cells (Fig. 6B). These results indicated that active Rap1 alone is sufficient to induce neurite outgrowth, and that Rap1 appeared to be activated downstream of Dok-4 in TGW cells.
To further confirm the role of Rap1 in neurite outgrowth, TGW cells or TGW(Dok-4) cells were transfected with a GFP-tagged Rap1GAP construct or a GFP-tagged dominant negative Rap1 mutant (RapN17) in which the serine at position 17 was replaced with asparagine. As shown in Fig. 7A,B, GDNF-dependent neurite outgrowth was markedly impaired by expression of these proteins. In addition, sustained ERK activation was significantly decreased in GFP-Rap1GAP or GFP-RapN17-expressing TGW(Dok-4) cells (Fig. 7C).
|
|
| Discussion |
|---|
|
|
|---|
Although the mechanism underlying Dok-4-induced neurite outgrowth in TGW cells is not fully understood, it appears to be dependent on phosphorylation mediated by RET activation. Consistent with this view, we found that Dok-4 residues Y187, Y220 and Y270, tyrosines conserved between Dok-4 proteins from a wide range of species as well as with Dok-5 and -6, may act as phosphorylation sites responsible for the sustained ERK activation in response to GDNF (Fig. 4). In addition, these conserved tyrosines were found to be necessary for full Dok-4 activity and induction of marked neurite outgrowth by TGW cells (Fig. 5). As tyrosine phosphorylation was still detected in each Dok-4 mutant tested, it is possible that phosphorylation at multiple tyrosine residues is required for the binding of adaptor or effector proteins to Dok-4. Alternatively, the tyrosines may be involved in maintaining the proper three dimensional structure of Dok-4. Exact determination of the phosphorylation sites in Dok-4 by phosphopeptide mapping or mass spectrometry is the subject of further investigation.
Exogenous expression of Dok-4 also induced neurite outgrowth of rat hippocampal neurons. It is interesting to note that Dok-4 expression showed a marked effect on neurite outgrowth without GDNF stimulation. This suggested that Dok-4 was activated in primary hippocampal neurons under our culture conditions in the absence of GDNF. Despite the presence of Dok-4 transcript in the primary neurons (Fig. 8A), we could not examine the endogenous Dok-4 protein expression in them because our anti-human Dok4 antibody did not recognize rat Dok-4. Thus, further investigation is necessary to elucidate the role of endogenous Dok-4 in neurite outgrowth of rat hippocampal neurons. In addition, a recent study revealed that the GDNF/NCAM pathway promoted axonal growth in rat hippocampal neurons independently of RET (Paratcha et al., 2003
), uncovering a possible synergistic interaction between the GDNF/RET and GDNF/NCAM pathways, although the NCAM pathway does seem to be dispensable for organogenesis and nerve regeneration in vivo (Enomoto et al., 2004
). It is also interesting to investigate whether Dok-4 is involved in the GDNF/NCAM pathway.
Role of Rap1 in GDNF/Ret signaling pathway
The enhancement of neurite outgrowth in TGW cells that overexpressed Dok-4 was significantly inhibited by PD98059, which indicated the importance of the ERK pathway in neuronal differentiation. Although it is currently not known which kinase is responsible for the sustained ERK phosphorylation mediated by Dok-4, our results showed that Dok-4 activated Rap1, a small GTPase of the Ras family, and is therefore a candidate mediator of sustained ERK activation (Vossler et al., 1997
; York et al., 1998
; Grewal et al., 2000a
; Stork, 2003
). In PC12 cells, an established model of NGF-induced neuronal differentiation, Rap1 is activated by NGF, which then increases the duration of ERK signaling by acting through the related Raf isoform B-Raf, thereby potentiating neuronal differentiation (Vossler et al., 1997
; York et al., 1998
; Annerén et al., 2000
; Grewal et al., 2000b
). In megakaryocytes, activation of Rap1, B-Raf, and ERK by thrombopoietin induces megakaryocytic differentiation (Delehanty et al., 2003
).
In addition to sustained ERK activation and cell differentiation, Rap1, like Ras, has been implicated in a wide range of biological processes, including cell proliferation and adhesion (Bos et al., 2001
; Bos, 2005
). It has also been reported that Rap1 functions as a Ras antagonist, opposing various actions of Ras including ERK pathway regulation (Cook et al., 1993
; Stork, 2003
; Bos, 2005
). Although the functional diversity of Rap1 has led to contradictory reports of its effects (Zwartkruis et al., 1998
), one of the unique features of Rap1 is its cell-type-specific regulation of ERK (Stork et al., 2003). To our knowledge, the role of Rap1 in the GDNF/RET signaling pathway has not been investigated previously. Our present study showed that GDNF stimulation induced Rap1 activation, which was clearly enhanced by Dok-4 expression. Expression of the constitutively active RapV12 induced neurite outgrowth in the absence of GDNF stimulation and in Dok-4-depleted cells (Fig. 6), which indicated that Rap1, acting downstream of Dok-4, may play a crucial role in the neuronal differentiation of TGW cells. By contrast, expression of the dominant negative Rap1 mutant or Rap1GAP markedly impaired neurite outgrowth from TGW cells as well as from hippocampal neurons. However, as Rap1 activation was not detected in TGW(Dok-4) cells 24 hours after GDNF stimulation (Fig. 6A), it may be unnecessary for maintaining neurite outgrowth. In addition, our study did not elucidate the molecular mechanism by which Dok-4 activated Rap1. Interaction between endogenous Dok-4 and Rap1 or Rap1 guanine nucleotide exchange factors (GEFs) such as C3G and PDZ-GEFs was not detected in immunoprecipitation assays (data not shown). Further experiments are required to determine the mechanism of how Dok-4 activates Rap1.
In addition to Dok-4, Dok-5 and -6 were recently identified as new members of the p62dok family. In contrast to Dok-1-3, which are expressed in hematopoietic tissues (Cristofano et al., 1998
; Cong et al., 1999
), Dok-4-6 are mainly expressed in the central and peripheral nervous systems, partially colocalized with RET. Together with the finding that Dok-4-6 show only remote sequence similarity to Dok-1-3, it appears that Dok-4-6 constitute a p62dok subfamily. Recent overexpression studies have shown that Dok-5 and -6 also associate with RET and promote neurite outgrowth in rat PC12 and mouse Neuro 2A cells in response to GDNF stimulation, although the role of endogenous Dok-5 and -6 remain to be clearly demonstrated (Grimm et al., 2001
; Crowder et al., 2004
). Nonetheless, owing to the sequence and structural similarities between Dok-4-6, it is important to clarify the level of functional divergence, synergism, and complementation between these proteins in GDNF/RET-dependent neuronal differentiation.
|
| Materials and Methods |
|---|
|
|
|---|
Antibodies
Rabbit anti-Dok-4 polyclonal antibody was developed against a 19 C-terminal amino acid fragment of Dok-4 and affinity-purified using the immunizing peptide. Anti-Rap1 polyclonal antibody and anti-Ras monoclonal antibody were purchased from Upstate. Other antibodies used included anti-p42/44 ERK polyclonal antibody, anti-phospho p42/44 ERK polyclonal antibody, anti-AKT polyclonal antibody, anti-phospho-AKT monoclonal antibody (Cell Signaling Technology) and anti-MAP2 monoclonal antibody (Upstate).
Cell culture and quantification of neurite outgrowth
TGW cells were maintained at 37°C in a humidified atmosphere of 5% CO2. TGW cells were grown in Dulbecco's modified Eagle's medium supplemented with 8% calf serum. For quantification of neurite outgrowth, TGW cells were cultured for 48 hours in medium with or without 50 ng/ml GDNF or inhibitors (18 µM PD98059, 15 µM LY294002 and 20 µM SP600125, added 60 minutes prior to GDNF stimulation). Neurite length was determined by tracing the entire length of the process, and total length calculated using the software program WinROOF (Mitani Corp., Fukui, Japan). At least 100 TGW cells were evaluated in each culture.
RNA interference
The siRNA-mediated knockdown of Dok-4 protein expression was performed using a previously described method (Enomoto et al., 2005
). The targeted sequence that effectively silenced Dok-4 expression was (sense sequence) 5'-AACAGACAGATCGCTTCAATG-3' (nucleotides 401-421). The sequence was searched against the human genome using BLAST to ensure that only the Dok-4 gene was targeted, and then the 21-nucleotide synthetic duplexes prepared by Qiagen. For siRNA annealing, 20 µM single stranded siRNA was incubated in siRNA Suspension Buffer (QIAGEN) for 1 minute at 90°C, followed by 1 hour at 37°C. TGW cells were transfected with either Dok-4-specific siRNA or 21-nucleotide irrelevant RNA (Qiagen) as a control using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Suppression of Dok-4 in the corresponding transfectants was confirmed by western blot analysis. siRNA-resistant Dok-4 was created by introducing two silent mutations at nucleotide positions 408 and 411 (5'-AACAGACAGATCGCTTCAATG-3', mutations underlined).
Immunofluorescent staining
TGW cells were plated on collagen I (10 µg/ml, Upstate)-coated coverslips or glass base dishes, and fixed with methanol for 10 minutes and then 10% bovine serum albumin for 10 minutes. The fixed cells were then stained with the indicated antibodies, and fluorescence examined using a confocal laser-scanning microscope (Fluoview FV500, Olympus).
Rat hippocampal neurons were plated on poly-D-lysine (100 µg/ml, Sigma) and laminin (50 µg/ml, IWAKI, Tokyo, Japan)-coated coverslips or glass base dishes, and then fixed with 3.7% formaldehyde in PBS for 10 minutes at room temperature, followed by treatment for 10 minutes with 0.05% Triton X-100 on ice and then 10% bovine serum albumin for 10 minutes. Neurons were immunostained with the indicated antibodies and fluorescence examined using a confocal laser-scanning microscope (Fluoview FV500, Olympus).
Rap1 activity assay
GDNF-treated or untreated TGW cells were lysed on ice for 10 minutes in lysis buffer (50 mM Tris-HCl (pH 7.4), 0.5 M NaCl, 1% NP40, 2.5 mM MgCl2, 10% glycerol, 1 mM sodium orthovanadate, 250 µM PMSF, 10 µg/ml aprotinin, and 10 µg/ml leupeptin) and the resulting lysates centrifuged at 15,000 g at 4°C for 5 minutes. Supernatants were added to 50 µg Ral GDS-RBD agarose beads (glutathione-Sepharose beads pre-coupled to GST protein fused with the Ras-binding domain of RalGDS) and incubated at 4°C for 45 minutes with gentle rotation. The beads were then washed four times in lysis buffer and boiled in SDS sample buffer. The amount of GTP-bound Rap1 was analyzed by immunoblotting with anti-Rap1 antibody.
Ras activity assay
GDNF-treated or untreated TGW cells were lysed on ice for 10 minutes in lysis buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 1% NP-40, 10 mM MgCl2, 1 mM EDTA and 10% glycerol, 1 mM sodium orthovanadate, 250 µM PMSF, 10 µg/ml aprotinin and 10 µg/ml leupeptin) and the lysates centrifuged at 15,000 g at 4°C for 5 minutes. Supernatants were added to 5 µg Raf-1 RBD agarose beads (glutathione-Sepharose beads pre-coupled to GST protein fused with the Ras-binding domain of Raf-1) and incubated at 4°C for 45 minutes with gentle rotation. The beads were washed four times in lysis buffer and boiled in SDS sample buffer. The amount of GTP-bound Ras was analyzed by immunoblotting with anti-Ras antibody.
Primary culture of rat hippocampal neurons
Fetuses were obtained at E19 from timed pregnant Sprague Dawley rats (Japan SLC company). Primary hippocampal neurons were prepared according to published protocols (Inagaki et al., 2001
; Yoshimura et al., 2005
). Briefly, hippocampi were dissociated by treatment with papain (500 µg/ml 60 minutes at 37°C), followed by trituration. Dissociated neurons were seeded (1.5x106 cells per 35 mm dish) on glass-based dishes coated with poly-D-lysine (PDL; Sigma) and laminin (Iwaki, Tokyo, Japan) in Neurobasal medium (Gibco) in the presence of supplement B27 (Gibco) and 100 mM L-glutamine, and kept at 37°C under 5% CO2. At 12 hours after plating, cultured neurons were transfected with either wild-type or mutant Dok-4 using a Neuroporter (Gene Therapy System) according to the manufacturer's instruction. After 3 days culture, neurons were fixed in 3.7% formaldehyde and stained with anti-MAP2 antibody for the morphometric analysis of neurite length.
Dok-4 and Ret RT-PCR
Total RNA was isolated using RNeasy Mini (Qiagen) and cDNA transcribed using Superscript (Invitrogen). RT-PCR was performed with primers specific to rat Dok-4 (5'-GAGCAGACAGATCGCTTCAA-3' and 5'-CCTGCCTAGGCTTTGGCTTA-3'), RET (5'-CCGATGGCACTAGCACTGGGTTCC-3' and 5'-ATTTTGCCGCTGAGGGTGAAACCA-3') and actin (5'-CACCACAGCTGAGAGGGAAAT-3' and 5'-CCACCAGACAGCACTGTGTTG-3').
Data analysis
Data are presented as mean ± s.e (standard error). Statistical significance was evaluated by Student's t-test.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Airaksinen, M. S. and Saarma, M. (2002). The GDNF family: signaling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383-394.[CrossRef][Medline]
Annerén, C., Reedquist, K. A., Bos, J. L. and Welsh, M. (2000). GTK, a Src-related tyrosine kinase, induces nerve growth factor-independent neurite outgrowth in PC12 cells through activation of the Rap1 pathway. J. Biol. Chem. 275, 29153-29161.
Besset, V., Scott, R. P. and Ibanez, C. F. (2000). Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275, 39159-39166.
Bos, J. L. (2005). Linking Rap to cell adhesion. Curr. Opin. Cell Biol. 17, 123-128.[CrossRef][Medline]
Bos, J. L., Rooij, J. D. and Reedquist, K. A. (2001). Rap1 signaling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2, 369-377.[CrossRef][Medline]
Brazil, D. P., Park, J. and Hemmings, B. A. (2002). PKB binding proteins: getting in on the Akt. Cell 111, 293-303.[CrossRef][Medline]
Cai, D., Dhe-Paganon, S., Melendez, P. A., Lee, J. and Shoelson, S. E. (2003). Two new substrates in insulin signaling, IRS/DOK4 and IRS/DOK5. J. Biol. Chem. 278, 25323-25330.
Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B. and Clarkson, B. (1997). p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197-204.[CrossRef][Medline]
Chao. M. V. (2003). Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat. Rev. Neurosci. 4, 299-309.[CrossRef][Medline]
Cong, F., Yuan, B. and Goff, S. P. (1999). Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol. Cell. Biol. 19, 8314-8325.
Cook, S. J., Rubinfeld, B., Albert, I. and McCormick, F. (1993). RapV12 antagonizes Ras-dependent activation of ERK and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12, 3475-3485.[Medline]
Cristofano, A. D., Carpino, N., Dunant, N., Friedland, G., Kobayashi, R., Strife, A., Wisniewski, D., Clarkson, B., Pandolfi, P. P. and Resh, M. D. (1998). Molecular cloning and characterization of p 56dok-2 defines a new family of Ras GAP-binding proteins. J. Biol. Chem. 273, 4827-4830.
Crowder, R. J., Enomoto, H., Yang, M., Johnson E. M., Jr and Milbrandt, J. (2004). Dok-6, novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J. Biol. Chem. 279, 42072-42081.
Datta, S. R., Brunet, A. and Greenberg, M. E. (1999). Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
Delehanty, L. L., Mogass, M., Gonias, S. L., Racke, F. K., Johnstone, B. and Goldfarb, A. N. (2003). Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation. Blood 101, 1744-1751.
Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fekete, C., Ponder, B. A. and Munnich, A. (1994). Mutations of RET proto-oncogene in Hirschsprung's disease. Nature 367, 319-320.[CrossRef][Medline]
Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., Murakumo, Y., Usukura, J., Kaibuchi, K. and Takahashi, M. (2005). Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev. Cell 9, 389-402.[CrossRef][Medline]
Enomoto, H., Hughes, I., Golden, J., Baloh, R. H., Yonemura, S., Heuckeroth, R. O., Johnson, E. M., Jr and Milbrandt, J. (2004). GFRalpha1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration. Neuron 18, 623-636.
Franke, B., Akkerman, J. W. and Bos, J. L. (1997). Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J. 16, 252-259.[CrossRef][Medline]
Fukuda, T., Kiuchi, K. and Takahashi, M. (2002). Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J. Biol. Chem. 277, 19114-19121.
Fukuda, T., Asai, N., Enomoto, A. and Takahashi, M. (2005). Activation of v-Jun amino-terminal kinase by GDNF induces G2/M cell cycle delay kinked with actin reorganization. Genes Cells. 10, 655-663.
Grewal, S. S., Fass, D. M., Yao, H., Ellig, C. L., Goodman, R. H. and Stork, P. J. (2000a). Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J. Biol. Chem. 275, 34433-34441.
Grewal, S. S., Horgan, A. M., York, R. D., Withers, G. S., Banker, G. A. and Stork, P. J. (2000b). Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J. Biol. Chem. 275, 3722-3728.
Grimm, J., Sachs, M., Britsch, S., Di Cesare, S., Schwarz-Romond, T., Alitalo, K. and Birchmeier, W. (2001). Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 154, 345-354.
Hayashi, H., Ichihara, M., Iwashita, T., Murakami, H., Shimono, Y., Kawai, K., Kurokawa, K., Murakumo, Y, Imai, T., Funahashi, H. et al. (2000). Characterization of intracellular signals via tyrosine 1092 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19, 4469-4475.[CrossRef][Medline]
Hayashi, Y., Iwashita, T., Murakami, H., Kato, Y., Kawai, K., Kurokawa, K., Tohnai, I., Ueda, M. and Takahashi, M. (2001). Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation. Biochem. Biophys. Res. Commun. 281, 682-689.[CrossRef][Medline]
Herrmann, C., Horn, G., Spaargaren, M. and Wittinghofer, A. (1996). Differential interaction of the Ras family GTP-binding proteins H-Ras Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271, 6794-6800.
Ichihara, M., Murakumo, Y. and Takahashi, M. (2004). RET and neuroendocrine tumors. Cancer Lett. 204, 197-211.[CrossRef][Medline]
Inagaki, N., Chihara, K., Arimura, N., Menager, C., Kawano, Y., Matsuo, N., Nishimura, T., Amano, M. and Kaibuchi, K. (2001). CRMP-2 induces axons in cultured hippocampal neurons. Nat. Neurosci. 4, 781-782.[CrossRef][Medline]
Jing, S., Wen, D., Yu, Y., Holst, P. L., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J.-C. et al. (1996). GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-
. Cell 85, 1113-1124.[CrossRef][Medline]
Kitayama, H., Matsuzaki, T., Ikawa, Y. and Noda, M. (1990). Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations. Proc. Natl. Acad. Sci. USA 87, 4284-4288.
Klein, R. D., Sherman, D., Ho, W.-H., Stone, D., Bennett, G. L., Moffat, B., Vandlen, R., Simmons, L., Gu, Q., Hongo, J.-A. et al. (1997). A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717-721.[CrossRef][Medline]
Kodama, Y., Asai, N., Kawai, K., Jijiwa, M., Murakumo, Y., Ichihara, M. and Takahashi, M. (2005). The RET proto-oncogene: a molecular therapeutic target in thyroid cancer. Cancer Sci. 96, 143-148.[CrossRef][Medline]
Lemay, S., Davidson, D., Latour, S. and Veillette, A. (2000). Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol. Cell. Biol. 20, 2743-2745.
Manié, S., Santoro, M., Fusco, A. and Billaud, M. (2001). The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet. 17, 580-589.[CrossRef][Medline]
Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.[CrossRef][Medline]
Moore, M. W., Klein, R. D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Richardt, L. F., Ryan, A. M., Carver, M. K. and Rosenthal, A. (1996). Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79.[CrossRef][Medline]
Murakami, H., Yamamura, Y., Shimono, Y., Kawai, K., Kurokawa, K. and Takahashi, M. (2002). Role of Dok1 in cell signaling mediated by RET tyrosine kinase. J. Biol. Chem. 277, 32781-32790.
Nelms, K., Snow, A. L., Hu-Li, J. and Paul, W. E. (1998). FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 9, 13-24.[CrossRef][Medline]
Nozaki, C., Asai, N., Iwashita, T., Iwata, Y., Horibe, K., Klein, R. D., Rosenthal, A. and Takahashi, M. (1998). Calcium-dependent Ret activation by GDNF and neurturin. Oncogene 16, 293-299.[CrossRef][Medline]
Paratcha, G., Ledda, F. and Ibanez, C. F. (2003). The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113, 867-879.[CrossRef][Medline]
Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A. C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J. et al. (1996). Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73-76.[CrossRef][Medline]
Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M. and Kaariainen, H. (1994). Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 377-378.[CrossRef][Medline]
Sanchez, M. P., Silos, S., Frisen, I. J., He, B., Lira, S. A. and Barbacid, M. (1996). Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70-73.[CrossRef][Medline]
Schuchardt, A., D'Agati, V., Larsson, B. L., Costantini, F. and Pachnis, V. (1994). Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383.[CrossRef][Medline]
Segouffin-Carius, C. and Billaud, M. (2000). Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J. Biol. Chem. 275, 3568-3576.
Stork, P. J. (2003). Dose Rap1 deserve a bad Rap? Trends Biochem. Sci. 28, 267-275.[CrossRef][Medline]
Takahashi, M. (2001). The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 12, 361-373.[CrossRef][Medline]
Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F. et al. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.[CrossRef][Medline]
Vossler, M. R., Yao, H., York, R. D., Pan, M. G., Rim, C. S. and Stork, P. J. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89, 73-82.[CrossRef][Medline]
Whitford, K. L., Dijkhuizen, P., Polleux, F. and Ghosh, A. (2002). Molecular control of cortical dendrite development. Annu. Rev. Neurosci. 25, 127-149.[CrossRef][Medline]
Yamanashi, Y. and Baltimore, D. (1997). Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88, 205-211.[CrossRef][Medline]
York, R. D., Yao, H., Dillon, T., Ellig, C. L., Eckert, S. P., McCleskey, E. W. and Stork, P. J. S. (1998). Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392, 622-626.[CrossRef][Medline]
Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A. and Kaibuchi, K. (2005). GSK-3b regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149.[CrossRef][Medline]
Zwartkruis, F. J., Wolthuis. R. M., Nabben, N. M., Franke, B. and Bos, J. L. (1998). Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signaling. EMBO J. 17, 5905-5912.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
A. Gerard, M. Ghiotto, C. Fos, G. Guittard, D. Compagno, A. Galy, S. Lemay, D. Olive, and J. A. Nunes Dok-4 Is a Novel Negative Regulator of T Cell Activation J. Immunol., June 15, 2009; 182(12): 7681 - 7689. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||